232 related articles for article (PubMed ID: 9222682)
1. Primary biliary cirrhosis: Dutch application of the Mayo Model before and after orthotopic liver transplantation.
van Dam GM; Verbaan BW; Therneau TM; Dickson ER; Malinchoc M; Murtaugh PA; Huizenga JR; Gips CH
Hepatogastroenterology; 1997; 44(15):732-43. PubMed ID: 9222682
[TBL] [Abstract][Full Text] [Related]
2. Confirmation of the role of the Mayo Risk Score as a predictor of resource utilization after orthotopic liver transplantation for primary biliary cirrhosis.
Gilroy RK; Lynch SV; Strong RW; Kerlin P; Balderson GA; Stuart KA; Crawford DH
Liver Transpl; 2000 Nov; 6(6):749-52. PubMed ID: 11084062
[TBL] [Abstract][Full Text] [Related]
3. Major clinical events, signs and severity assessment scores related to actual survival in patients who died from primary biliary cirrhosis. A long-term historical cohort study.
van Dam GM; Gips CH; Reisman Y; Maas KW; Purmer IM; Huizenga JR; Verbaan BW
Hepatogastroenterology; 1999; 46(25):108-15. PubMed ID: 10228773
[TBL] [Abstract][Full Text] [Related]
4. Survival probabilities of Pugh-Child-PBC classified patients in the euricterus primary biliary cirrhosis population, based on the Mayo clinic prognostic model. Euricterus Project Management Group.
Reisman Y; van Dam GM; Gips CH; Lavelle SM; Euricterus PM
Hepatogastroenterology; 1997; 44(16):982-9. PubMed ID: 9261586
[TBL] [Abstract][Full Text] [Related]
5. Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Group.
Talwalkar JA; Seaberg E; Kim WR; Wiesner RH
Liver Transpl; 2000 Nov; 6(6):753-8. PubMed ID: 11084063
[TBL] [Abstract][Full Text] [Related]
6. Optimal timing of liver transplantation for primary biliary cirrhosis.
Kim WR; Wiesner RH; Therneau TM; Poterucha JJ; Porayko MK; Evans RW; Klintmalm GB; Crippin JS; Krom RA; Dickson ER
Hepatology; 1998 Jul; 28(1):33-8. PubMed ID: 9657093
[TBL] [Abstract][Full Text] [Related]
7. Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates.
Kim WR; Wiesner RH; Poterucha JJ; Therneau TM; Benson JT; Krom RA; Dickson ER
Liver Transpl; 2000 Jul; 6(4):489-94. PubMed ID: 10915173
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients.
ter Borg PC; Schalm SW; Hansen BE; van Buuren HR;
Am J Gastroenterol; 2006 Sep; 101(9):2044-50. PubMed ID: 16848809
[TBL] [Abstract][Full Text] [Related]
9. Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?
Kilmurry MR; Heathcote EJ; Cauch-Dudek K; O'Rourke K; Bailey RJ; Blendis LM; Ghent CN; Minuk GY; Pappas SC; Scully LJ; Steinbrecher UP; Sutherland LR; Williams CN; Worobetz LJ
Hepatology; 1996 May; 23(5):1148-53. PubMed ID: 8621147
[TBL] [Abstract][Full Text] [Related]
10. Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis?
Krzeski P; Zych W; Kraszewska E; Milewski B; Butruk E; Habior A
Hepatology; 1999 Oct; 30(4):865-9. PubMed ID: 10498635
[TBL] [Abstract][Full Text] [Related]
11. Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis.
Heathcote EJ; Stone J; Cauch-Dudek K; Poupon R; Chazouilleres O; Lindor KD; Petz J; Dickson ER; Poupon RE
Liver Transpl Surg; 1999 Jul; 5(4):269-74. PubMed ID: 10388499
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.
Jacob DA; Neumann UP; Bahra M; Klupp J; Puhl G; Neuhaus R; Langrehr JM
Clin Transplant; 2006; 20(2):211-20. PubMed ID: 16640529
[TBL] [Abstract][Full Text] [Related]
13. Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years.
Su CW; Hung HH; Huo TI; Huang YH; Li CP; Lin HC; Lee PC; Lee SD; Wu JC
Liver Int; 2008 Nov; 28(9):1305-13. PubMed ID: 18346129
[TBL] [Abstract][Full Text] [Related]
14. Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation.
Nashan B; Schlitt HJ; Tusch G; Oldhafer KJ; Ringe B; Wagner S; Pichlmayr R
Hepatology; 1996 May; 23(5):1105-11. PubMed ID: 8621141
[TBL] [Abstract][Full Text] [Related]
15. [Liver transplantation for primary biliary cirrhosis: retrospective analysis of results at a single center].
Jacob DA; Neumann UP; Bahra M; Langrehr JM; Neuhaus P
Dtsch Med Wochenschr; 2006 Oct; 131(42):2327-32. PubMed ID: 17043982
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH
Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401
[TBL] [Abstract][Full Text] [Related]
17. Mayo risk score for primary biliary cirrhosis: a useful tool for the prediction of course after liver transplantation?
Jacob DA; Bahra M; Schmidt SC; Schumacher G; Weimann A; Neuhaus P; Neumann UP
Ann Transplant; 2008; 13(3):35-42. PubMed ID: 18806733
[TBL] [Abstract][Full Text] [Related]
18. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis.
Kim WR; Poterucha JJ; Wiesner RH; LaRusso NF; Lindor KD; Petz J; Therneau TM; Malinchoc M; Dickson ER
Hepatology; 1999 Jun; 29(6):1643-8. PubMed ID: 10347102
[TBL] [Abstract][Full Text] [Related]
19. Value of baseline platelet count for prediction of complications in primary biliary cirrhosis patients treated with ursodeoxycholic acid.
Huang YL; Yao DK; Hu ZD; Sun Y; Chen SX; Zhong RQ; Deng AM
Scand J Clin Lab Invest; 2013 Feb; 73(1):17-23. PubMed ID: 23294193
[TBL] [Abstract][Full Text] [Related]
20. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
